SCCR Indonesia

Business Services · Indonesia · 51-200 Employees

View Company Info for Free

Overview

Headquarters

/sm PO Box 1054, Semarang, Central Java,...

Phone Number

+62 8113217333

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1

About SCCR Indonesia

SCCR Indonesia is a leading pharmaceutical company specializing in stem cell therapies and cancer research. The company is committed to delivering globally standardized medical innovations and has obtained necessary permits and certifications from health authorities. Equipped with advanced laboratory facilities and supported by international researchers, SCCR Indonesia focuses on research-based healthcare solutions to enhance patient quality of life and advance biomedical science. Their intended clients include healthcare providers and patients seeking innovative treatments in the fields of stem cell therapy and cancer care.Explore more
SCCR Indonesia's Social MediaPopular SearchesSCCR IndonesiaPt Sccr IndonesiaSCCR Indonesia (Stem Cell and Cancer Research)Stem Cell and Cancer ResearchSIC Code 87,873NAICS Code 54,541Show more

Is SCCR Indonesia your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

SCCR Indonesia is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

SCCR Indonesia is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SCCR Indonesia.

SCCR Indonesia Tech Stack

A closer look at the technologies used by SCCR Indonesia

Top Business Services Companies

Frequently Asked Questions Regarding SCCR Indonesia

What is SCCR Indonesia's official website?
SCCR Indonesia's official website is www.sccr.id
What is SCCR Indonesia's Revenue?
SCCR Indonesia's revenue is <$5 Million
What is SCCR Indonesia's SIC code?
SCCR Indonesia's SIC: 87,873
What is SCCR Indonesia's NAICS code?
SCCR Indonesia's NAICS: 54,541
How many employees does SCCR Indonesia have?
SCCR Indonesia has 51-200 employees
What industry does SCCR Indonesia belong to?
SCCR Indonesia is in the industry of: Business Services, Research & Development
What technology does SCCR Indonesia use?
Some of the popular technologies that SCCR Indonesia uses are: WordPress.org, PHP, jsDelivr
How do I contact SCCR Indonesia?
SCCR Indonesia contact info: Phone number: +62 8113217333 Website: www.sccr.id
What does SCCR Indonesia do?

SCCR Indonesia is a leading pharmaceutical company specializing in stem cell therapies and cancer research. The company is committed to delivering globally standardized medical innovations and has obtained necessary permits and certifications from health authorities. Equipped with advanced laboratory facilities and supported by international resear... chers, SCCR Indonesia focuses on research-based healthcare solutions to enhance patient quality of life and advance biomedical science. Their intended clients include healthcare providers and patients seeking innovative treatments in the fields of stem cell therapy and cancer care.Read More

What are SCCR Indonesia social media links?
SCCR Indonesia Linkedin page
Is SCCR Indonesia a public company?
SCCR Indonesia is private company therefore does not currently have an official ticker symbol
See more information about SCCR Indonesia

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.